R75251, A NEW INHIBITOR OF STEROID-BIOSYNTHESIS

被引:58
作者
BRUYNSEELS, J [1 ]
DECOSTER, R [1 ]
VANROOY, P [1 ]
WOUTERS, W [1 ]
COENE, MC [1 ]
SNOECK, E [1 ]
RAEYMAEKERS, A [1 ]
FREYNE, E [1 ]
SANZ, G [1 ]
VANDENBUSSCHE, G [1 ]
VANDENBOSSCHE, H [1 ]
WILLEMSENS, G [1 ]
JANSSEN, PAJ [1 ]
机构
[1] JANSSEN RES FDN,AUBERVILLIERS,FRANCE
关键词
human; rat; testicular and adrenal steroid biosynthesis;
D O I
10.1002/pros.2990160409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
R 75251, a new imidazole derivative, inhibited the conversion of androgens to estrogens, of progestins to androstenedione and testosterone, and of 11‐deoxycorticosterone to corti‐costerone in human placenta microsomes, subcellular fraction of rat testis, bovine adreno‐cortical mitochondria, in cultured rat granulosa, testicular and adrenal cells, respectively. In vitro, no effect on cholesterol synthesis and cholesterol side‐chain cleavage was found at concentrations up to 10 μM. In rat granulosa cells, no effect on progesterone production was detected. In vitro, no effect on steroid radioligand binding was observed. In male volunteers, a single dose of 300 mg of R 75251 significantly lowered plasma testosterone and estradiol for 24 hours and increased plasma concentration of 17α‐hydroxy‐progesterone and progesterone. As compared with ketoconazole high dose (600 mg b.i.d), R 75251 (300 mg b.i.d) was at least as efficacious as inhibitor of testosterone synthesis when studied during ACTH stimulation. In contrast to ketoconazole, R 75251 did not significantly affect circulating adrenal androgen levels in male volunteers. Precursors of gluco‐ and mineralocorticoids such as 11‐deoxycortisol and 11‐deoxycorticosterone accumulated more than after ketoconazole administration. The data show that the cytochrome P450‐dependent aromatase, 17‐hydroxylase/17,20‐lyase, and 11‐hydroxylase are the target enzymes for R 75251. Copyright © 1990 Wiley‐Liss, Inc., A Wiley Company
引用
收藏
页码:345 / 357
页数:13
相关论文
共 25 条
[11]   THE EFFECT OF KETOCONAZOLE ON ADRENAL AND TESTICULAR STEROIDOGENESIS INVITRO [J].
LAMBERT, A ;
MITCHELL, R ;
ROBERTSON, WR .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (22) :3999-4004
[12]   KETOCONAZOLE BLOCKS ADRENAL STEROIDOGENESIS BY INHIBITING CYTOCHROME-P450-DEPENDENT ENZYMES [J].
LOOSE, DS ;
KAN, PB ;
HIRST, MA ;
MARCUS, RA ;
FELDMAN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (05) :1495-1499
[13]  
MASON JI, 1985, BIOCHEM PHARMACOL, V34, P1087, DOI 10.1016/0006-2952(85)90613-6
[15]   KETOCONAZOLE BLOCKS ADRENAL-STEROID SYNTHESIS [J].
PONT, A ;
WILLIAMS, PL ;
LOOSE, DS ;
FELDMAN, D ;
REITZ, RE ;
BOCHRA, C ;
STEVENS, DA .
ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) :370-372
[16]   KETOCONAZOLE-INDUCED INCREASE IN ESTRADIOL-TESTOSTERONE RATIO - PROBABLE EXPLANATION FOR GYNECOMASTIA [J].
PONT, A ;
GOLDMAN, ES ;
SUGAR, AM ;
SIITERI, PK ;
STEVENS, DA .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (08) :1429-1431
[17]   KETOCONAZOLE THERAPY IN ADVANCED PROSTATIC-CANCER [J].
TRACHTENBERG, J .
JOURNAL OF UROLOGY, 1984, 132 (01) :61-63
[18]  
VANDENBOSSCHE H, 1990, BIOCHEM SOC T, V18, P10
[19]   EFFECTS OF ETOMIDATE ON STEROID-BIOSYNTHESIS IN SUBCELLULAR-FRACTIONS OF BOVINE ADRENALS [J].
VANDENBOSSCHE, H ;
WILLEMSENS, G ;
COOLS, W ;
BELLENS, D .
BIOCHEMICAL PHARMACOLOGY, 1984, 33 (23) :3861-3868
[20]  
VANDENBOSSCHE H, 1987, PHARM CLIN USES INHI, P288